Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | PPARD | Q03181 | 4/20 | 0.57 |
| ▸ | PPARA | Q07869 | 4/20 | 0.57 |
| ▸ | F7 | P08709 | 4/20 | 0.57 |
| ▸ | F3 | P13726 | 4/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.57 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715767 | 1.00 | PPARG (0.57) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL20573726 | 1.00 | PPARG (0.57) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL26107677 | 0.95 | CA2 (0.62) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL18920300 | 0.93 | CA2 (0.56) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL18920298 | 0.93 | CA2 (0.56) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL10906977 | 0.92 | CA2 (0.59) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL687469 | 0.92 | CA2 (0.59) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL10906974 | 0.92 | CA2 (0.59) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL15375772 | 0.90 | PPARG (0.57) | PPARGALDH1A1PPARDPPARAF7 | |
| SCHEMBL15375773 | 0.90 | PPARG (0.57) | PPARGALDH1A1PPARDPPARAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115677489-A | Method for purifying arachidonic acid ethyl ester | 江苏海莱康生物科技有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-109731607-B | Preparation method of propyl sulfonic group modified SBA-15 and application of propyl sulfonic group modified SBA-15 in synthesis of structured phospholipid | 大连工业大学 | 2021-09-24 | — | — | CN | claimed |
| CN-109879905-B | Preparation method of naphthyl sulfonic group modified SBA-15 and application of naphthyl sulfonic group modified SBA-15 in synthesis of phospholipid rich in unsaturated fatty acid structure | 大连工业大学 | 2021-07-06 | — | — | CN | claimed |
| CN-109824719-B | Preparation method of phenylsulfonic-modified SBA-15 composite material and application of phenylsulfonic-modified SBA-15 composite material in synthesis of structured phospholipid | 大连工业大学 | 2021-07-06 | — | — | CN | claimed |
| CN-107543869-B | Method for simply, conveniently and rapidly determining 6 fatty acid ethyl esters in human whole blood | 复旦大学 | 2020-06-09 | — | — | CN | claimed |
| CN-110658268-A | Method for simultaneously detecting multiple ethanol non-oxidized metabolites in blood spots | 复旦大学 | 2020-01-07 | — | — | CN | claimed |
| CN-110585188-A | Lipids and lipid compounds for use as medicaments for the treatment of pain and methods of use thereof | 崔建国 | 2019-12-20 | — | — | CN | claimed |
| US-8617594-B2 | Stable pharmaceutical composition and methods of using same | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2013-12-31 | — | — | US | claimed |
| US-20130171251-A1 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2013-07-04 | — | — | US | claimed |
| CN-110087624-B | Skin temperature sensitive lipid composition and cosmetic composition | CJ第一制糖株式会社 | 2023-02-17 | — | — | CN | disclosed |
| CN-115677489-A | Method for purifying arachidonic acid ethyl ester | 江苏海莱康生物科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115677489-A | Method for purifying arachidonic acid ethyl ester | 江苏海莱康生物科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115586271-A | Method for rapidly determining ethyl ester type fatty acid by ester exchange method and application thereof | 天津市疾病预防控制中心 | 2023-01-10 | — | — | CN | disclosed |
| EP-3383380-B1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | BIOZEP AS (NO) | 2023-01-04 | — | — | EP | disclosed |
| US-20190284129-A1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | BIOZEP AS (NO) | 2019-09-19 | — | — | US | disclosed |
| EP-2429317-B2 | COMPOSITIONS RICH IN OMEGA-3 FATTY ACIDS WITH A LOW CONTENT IN PHYTANIC ACID | NATAC PHARMA S L (ES) | 2019-02-20 | — | — | EP | disclosed |
| WO-2017093732-A1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | BIOZEP AS (NO) | 2017-06-08 | — | — | WO | disclosed |
| EP-2429317-B1 | COMPOSITIONS RICH IN OMEGA-3 FATTY ACIDS WITH A LOW CONTENT IN PHYTANIC ACID | NATAC PHARMA S L (ES) | 2016-03-30 | — | — | EP | disclosed |
| US-9062275-B2 | Compositions rich in omega-3 fatty acids with a low content in phytanic acid | NATAC PHARMA, S.L. (ES) | 2015-06-23 | — | — | US | disclosed |
| US-20120053242-A1 | COMPOSITIONS RICH IN OMEGA-3 FATTY ACIDS WITH A LOW CONTENT IN PHYTANIC ACID | CELA VISTA PHARMACEUTICALS LIMITED (IE) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284129-A1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | APOB, ALOX12, NR1H2 | PPARG 392/4885ALDH1A1 417/4885PPARD 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.